Influenza vaccine from the US manufacturer sanofi pasteur:1110336
Ended Awarded
- Contract number
- 75N90020A00005
- Awardee
-
Sanofi Vaccines US Inc. UEI NCXBGGQ8YTU9
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Task orders
- 4 $307,860 obligated
Award facts
- Combined order value
- $307,860 Current and potential, with all options
- Last date to order 100% complete
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Institutes of Health Clinical Center awarded Sanofi Pasteur Inc. a blanket purchase agreement to deliver influenza vaccines in support of the agency's medical programs. Under the agreement and subsequent calls issued against the Pharmaceuticals and Drugs schedule, Sanofi Pasteur will supply its influenza virus vaccine through April 2025 from manufacturing locations in Swiftwater, Pennsylvania and Bethesda, Maryland. Vaccines will be provided on a firm-fixed-price basis under task orders valued from $0.00 to $139,025.20 to support the NIH Clinical Center's influenza vaccination efforts among patients and staff.
The blanket purchase agreement and associated calls aim to procure influenza vaccines from Sanofi Pasteur's domestic manufacturing facilities to promote influenza prevention at the NIH Clinical Center. No set-aside provisions were applied under the multiple award agreement or subsequent calls issued against the company's Pharmaceuticals and Drugs GSA schedule. Places of performance include Swiftwater, Pennsylvania and Bethesda, Maryland through April 2026. The vaccines provided under this vehicle are intended to bolster the NIH Clinical Center's influenza vaccination program efforts.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Sanofi pasteur:1110336 [23-013038] nfluenza virus vaccine | NIH Clinical Center | $86,294 | |
| Influenza vaccine from the US manufacturer | NIH Clinical Center | $82,541 | |
| Flu vaccine | NIH Clinical Center | $0 | |
| Influenza vaccine for NIH flu campaign from sanofi pasteur:1110336 [pots: 20-009219] | NIH Clinical Center | $139,025 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Modification | $0 | |
| Other Administrative Action | $0 |
Quick answers
Who was awarded contract 75N90020A00005?
75N90020A00005 was awarded to Sanofi Vaccines US Inc. by NIH Clinical Center (National Institutes of Health) on April 27, 2020.
How much is contract 75N90020A00005 worth?
Orders under 75N90020A00005 have obligated $307,860.
How many orders have been placed under contract 75N90020A00005?
4 orders have been placed under 75N90020A00005, the latest on August 24, 2023.
Who can order from contract 75N90020A00005?
75N90020A00005 is a multiple award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 75N90020A00005 under another contract?
Yes. 75N90020A00005 is a blanket purchase agreement under V797D50457, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75N90020A00005 competed?
The extent of competition for 75N90020A00005 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV